Eledon Pharmaceuticals, Inc.
@eledon_pharma
Targeting the CD40L pathway to develop potential treatments for organ or cell-based transplant, autoimmune and neurodegenerative diseases. $ELDN
ID: 1340390661103575040
https://eledon.com 19-12-2020 20:17:05
307 Tweet
220 Followers
33 Following
